We have analysed the importance of ®broblast growth factor 2 (FGF2) in tumor development. In a transgenic mouse model (Tyrp1-Tag) tumors form in the retinal pigment epithelium (RPE), invade surrounding tissues, and metastasize to lymph node and spleen. To address whether RPE tumor formation is dependent on FGF2, we generated FGF2-de®cient mice. Such mice appeared healthy and exhibited no impairment of growth or development. Tyrp1-Tag transgenic mice, which are lacking FGF2 (FGF27/7) developed RPE tumors that metastasize to spleen and lymph nodes. Tumor growth and survival rate are identical to Tyrp1-Tag transgenic littermates expressing FGF2. Cell lines were isolated from RPE tumors of wild-type and FGF2-de®cient mice. They grow in culture, are pigmented and form vascularized tumors, when injected subcutaneously into nude mice of either FGF27/7 or FGF2+/+ genetic background. Kinetics of tumor growth was identical and independent of presence of FGF2. Together, these results demonstrate that FGF2 is not essential for tumor formation of the RPE thus suggesting that tumor growth in general may not be dependent on FGF2.
Introduction
Pigmentation in mammals is con®ned to two ontogenetically dierent cell types, the neural crest-derived melanocytes found in skin, hair follicle or the choroid of the eye, and the pigment epithelium of the retina, a cell layer derived from the optic cup. Pigmentation genes control the migration of melanoblasts, the regulation of pigment cell-speci®c gene expression or the enzymatic reactions of the melanin biosynthetic pathway (del Marmol and Beermann, 1996; Jordan and Beermann, 2000) . Neural crest-derived melanocytes can result in tumors, which are known as cutaneous melanoma in skin and ocular or uveal melanoma in the eye. In addition, pigmented ocular tumors can develop from proliferating cells of the retinal pigment epithelium (Loeer et al., 1996) . In melanoma mouse models, which have been produced using the tyrosinase promoter linked to SV40 transforming sequences, tumors in the RPE and choroid-RPE interphase have been observed (Anand et al., 1994; Beermann et al., 1999; Bradl et al., 1991; Mintz and Klein-Szanto, 1992) . We recently used the promoter of the tyrosinaserelated protein 1 gene (Tyrp1) to target expression of SV40 T antigen (Tag) to the developing RPE . In this transgenic line, the transgene integrated on the Y chromosome, and 100% of the males developed tumors, which were pigmented and of epithelial origin. These tumors metastasized to inguinal lymph nodes and spleen .
Fibroblast growth factor 2 (FGF2; bFGF) belongs to a family of related proteins consisting of at least 22 members. In cell culture, FGF2 induces proliferation and migration. FGF2 was shown to be a potent angiogenic molecule in vivo and in vitro and was implicated in wound healing and tissue repair (Bikfalvi et al., 1997) . In tumor biology, FGF2 was longtime regarded as`the' tumor angiogenesis factor (Hanahan and Folkman, 1995) . It is expressed in ®brosarcoma and glioma cells (Bikfalvi et al., 1997) and was believed to be important in the growth of melanoma (Halaban et al., 1988) , glioblastoma (Takahashi et al., 1992) , hepatoma (Maret et al., 1995) , Leukemia (Menzel et al., 1996) , bladder cancer (O'Brien et al., 1997), ovarian cancer (Crickard et al., 1994) and breast cancer (el Yazidi and Boilly, 1995) . Elevated levels of FGF2 in the urine or serum of patients correlated with poor prognosis (Nguyen et al., 1994; Sliutz et al., 1995) .
FGF2 is expressed in the RPE (Rakoczy et al., 1993; Vagner et al., 1996) . In Xenopus and chicken, overexpression of FGF2 leads to transdierentiation of the developing RPE into neurons and glia cells (Opas and Dziak, 1994; Sakaguchi et al., 1997) . In the mouse, during early eye development, signaling from FGFs (FGF1 and FGF2) seems to decide upon neuroretinal versus pigment epithelial cell fate (Nguyen and Arnheiter, 2000) . FGF2 has been implicated in retinal degeneration, nitric oxide production or transduction of photoreceptors, and might act as a survival factor for the RPE (Bryckaert et al., 1999; Hackett et al., 1997) . To address the role of FGF2 in RPE tumor development, we used mice de®cient for FGF2, generated by homologous recombination in embryonic stem cells. FGF2-de®cient mice were bred to Tyrp1-Tag transgenic mice which develop eye tumors. Tumor cells from wild-type and FGF2-mutant animals had the same capacity to generate new tumors in nude mice independent of the host background, i.e. whether FGF2 is expressed or not. The results demonstrated that FGF2 is not required for RPE tumor formation and tumor growth in nude mice.
Results

Gene targeting at exon 2 of the mouse FGF2 gene locus
We have isolated and characterized the mouse FGF2 gene (not shown) and have disrupted the gene using a replacement targeting vector ( Figure 1a ). Breeding of heterozygous mutant mice generated the expected genotypes ( Figure 1b ) in a ratio consistent with the Mendelian pattern of inheritance. FGF27/7 mice lack FGF2 mRNA (Figure 1c ). They are viable and fertile, and give rise to normal sized litters. FGF27/7 mice grow at the same rate at heterozygous mutant or wildtype mice. Analysis of the principal organs, of bone development, and of skin sections (not shown) did not reveal any obvious dierences to wild-type mice.
RPE tumors develop in FGF27/7 mice
Morphology of retina in FGF27/7 mice is identical to FGF2+/+ mice, and both RPE and choroid are pigmented (not shown). FGF27/7 mice were mated to Tyrp1-Tag transgenic mice to analyse tumor development of the RPE . Macroscopic observations on Tyrp1-Tag FGF27/7 mice did not show any dierences in tumor development compared to Tyrp1-Tag FGF2+/+ mice. They developed eye tumors, and at 2 ± 3 months of age, pigmented cells were seen in inguinal lymph nodes and, in some mice, equally in spleen (Figure 2a,c ; not shown). Death of mice occurs at about 3 months, most probably caused by proliferation of tumor cells in brain and near the optic chiasm (Figure 2b,d ). Tyrp1-Tag transgenic mice with or without FGF2 (FGF2+/+, FGF2+/7, FGF27/7) exhibited the same mean life span of about 11.5 weeks and the same survival kinetics (Figure 2e ).
To assess whether FGF2 is implicated in the kinetics of tumor progression, we analysed eyes of 1 and 14 days old Tyrp1-Tag FGF2+/+ and Tyrp1-Tag FGF27/7 mice ( Figure 3 , not shown). In 1 day-old Tyrp1-Tag FGF2+/+ and Tyrp1-Tag FGF27/7 mice, tumors were present in the anterior part of the RPE (Figure 3b ,c) and the optic nerve (Figure 3h,i) . In 14-day-old Tyrp1-Tag FGF2+/+ and Tyrp1-Tag FGF27/7 mice, tumors were further advanced and the posterior eye cavity was ®lled with tumor cells (not shown). In both Tyrp1-Tag FGF2+/ + and Tyrp1-Tag FGF27/7 mice tumor cells were poorly pigmented or nonpigmented, but islets of pigmented cells were seen in the optic nerve (not shown). In conclusion, eye sections of newborn and 14-day-old Tyrp1-Tag FGF27/7 transgenic mice showed no dierence with respect to the development, frequency and location of tumors when compared to Tyrp1-Tag FGF2+/+ mice. Thus, absence of FGF2 does not aect RPE tumor formation in Tyrp1-Tag transgenic mice. Homologous recombination resulted in replacement of the KpnI ± XbaI fragment which includes the last 36 bp of exon 2, by a lacZ gene and the neo cassette (pgk-neo). Expected fragment sizes following BamHI digestion and use of probe A are indicated. Targeted clones were con®rmed using KpnI digestion and probe B. B BamHI, Bg BglII, K KpnI, X XbaI, Xh XhoI. (b) Southern blot analysis of ospring derived from heterozygous intercrosses. DNA was prepared, digested with BamHI and hybridized with probe A. The FGF2 genotype is indicated. The 7.5 kb wild-type fragment is found in the 129/Sv background. Due to a polymorphism, the wildtype fragment is smaller (6 kb) in C57BL/6J mice (not shown). (c) RT ± PCR analysis of kidney (ki) and lung (lu) RNA demonstrates absence of FGF2 mRNA in FGF homozygous (7/7) mutant mice. RT ± PCR using primers in exon 1 and exon 3 resulted in a 298 bp band speci®c for FGF2. C-negative control, C+ positive control (cDNA)
RPE tumor cells grow in culture and form tumors in nude mice
We asked whether FGF2-de®cient cell lines could be isolated, and whether they exhibit the capacity to form tumors in nude mice. RPE tumor cells were obtained from Tyrp1-Tag FGF2+/+, Tyrp1-Tag FGF2+/7 and Tyrp1-Tag FGF27/7 transgenic mice. Cells of either genotype do not grow in serum-free medium, and hence still require serum (not shown). Absence of FGF2 did not aect pigment production and proliferation ( Figure 4a ). Cells isolated from either genotype decreased pigmentation after several passages. We asked whether FGF2+/+ RPE tumor cells would express FGF2, and detected FGF2 mRNA in Tyrp1-Tag FGF2+/+ and Tyrp1-Tag FGF2+/7 cells ( Figure 4b ). As expected, FGF2 transcripts are lacking in Tyrp1-Tag FGF27/7 cells. Using Western blots, we detected expression of all three isoforms of FGF2 in extracts of RPE tumor cells (Figure 4c ), but were unable to detect any secretion of FGF2 in cell culture (not shown). This is in concordance with reported ®ndings, where FGF2 was not secreted from RPE cells in culture without further treatment (Mousa et al., 1999) .
RPE tumor cells were then analysed for growth in nude mice. Since tumor growth in nude mice is dependent on vascularization, we generated and used mice which carried both the nude genotype (Foxn1 nu homozygous) and were de®cient for FGF2 (FGF27/7). Following subcutaneous injection of FGF2+/+ and FGF27/7 tumor cells into nude mice (FGF2+/+ or FGF27/7) tumors were observed irrespective of presence of FGF2. In general, such tumors grew slowly and were largely unpigmented, but retained small areas of strong pigmentation (Figure 4d ). Tumors expressed SV40 T antigen homogenously, remained well separated and did not show invasion into the surrounding tissue (Figure 4e ± g). No metastasis was observed in these nude mice. We then asked whether kinetics and onset of proliferation is in¯uenced by absence of FGF2. We used RPE tumor cells de®cient in FGF2, which were injected into nude mice (FGF2+/+ and FGF27/7). Onset of growth started after 30 days, and progression of tumor growth was not signi®cantly dierent between FGF2+/+ nude hosts and those de®cient for FGF2 (Figure 4h ). In addition, we compared growth of FGF2+/+ tumor cells to FGF27/7 tumor cells, which were injected Mortality of Tyrp1-Tag transgenic mice was determined starting at the age of 5 weeks (FGF2+/+ n=15, FGF2+/7 n=18, FGF7/7 n=19). Survival curve and mean life span in FGF2 homozygous (7/7) mutant mice (11.7 weeks) was not dierent to wild-type (+/+), and heterozygous (+/7) mutant mice (mean life span of 11.6 and 11.5 weeks, respectively) We asked whether vascularization is aected in tumors arising from FGF2-de®cient cells. We analysed tumors generated in nude mice by immunohistochemistry using an anti-CD31 antibody, which is a marker for endothelial cells. Vessels were detected in all analysed tumors, and were not dierent between the genotype combinations (not shown, Figure 5a,b) . More quantitative analysis revealed no dierence of density and size of blood vessels between tumors arising from FGF2+/+ or FGF27/7 RPE tumor cells when injected into nude FGF2+/+ mice (FGF2+/+, 9.79+2.98 vessels per mm 2 ; FGF27/7, 10.30+2.98). We therefore conclude that expression of FGF2 from RPE tumor cells is not required for vascularization and tumor growth.
Discussion
In this paper, we were interested in the role of FGF2 in tumor development and have generated mice de®cient for FGF2. This FGF2 knockout is dierent from those published recently (Dono et al., 1998; Ortega et al., 1998; Zhou et al., 1998) . We have removed part of exon 2, to target potentially occurring transcripts from a putative alternative exon 1 (Zuniga Mejia Borja et al., 1996) . FGF2-de®cient mice where exon 1 of the gene was targeted, had revealed a mild phenotype, including speci®c neuronal defects, a reduced blood pressure, a decreased bone mass and a delay in wound healing (Dono et al., 1998; Montero et al., 2000; Ortega et al., 1998; Schultz et al., 1999; Vaccarino et al., 1999; Zhou et al., 1998) . We had performed a wound healing experiment and detected a delay in healing of skin wounds in our FGF27/7 mice in comparison to FGF2+/7 or wild-type littermates (not shown). Blood pressure is slightly reduced in our FGF27/7 mice in addition to dilated cardiomyopathy (Pellieux et al., 2001) . The phenotype of the FGF27/7 mice reported in this paper therefore corresponds to that of FGF27/7 mice which were generated by deleting exon 1 of the FGF2 gene (Dono et al., 1998; Ortega et al., 1998; Schultz et al., 1999; Zhou et al., 1998) . Since the FGF2 knockout reported here would aect transcripts from the`normal' exon 1 and a hypothetical`alternative' exon 1, we can conclude that absence of major eects in reported FGF2 knockout mice is not due to potentially present transcripts.
We had recently generated a mouse model for tumors of the retinal pigment epithelium, which metastasize to lymph nodes and spleen . In this paper, we demonstrate using FGF2-de®cient mice that tumors from the retinal pigment epithelium develop in absence of FGF2. In both Tyrp1-Tag FGF2+/+ and Tyrp1-Tag FGF27/7 mice tumors developed from two main foci, one in the anterior part of the eye and one in the region of the optic nerve. Progression followed the same path and rate, with invasion of the optic cavity by proliferating cells derived from the ciliary body and from the optic nerve. Analysis of RPE derived tumors and subcutaneous tumors in nude mice did not reveal dierences between FGF27/7 and wild-type mice. FGF2 is dispensable for the neovascularization of the retina and the choroid (Tobe et al., 1998) , even though it is normally expressed in these locations (Ogata et al., 1995; Frank et al., 1996) . We add here additional data showing that FGF2 does not play a relevant role in ocular tumors originating from the RPE, a tissue known to express FGF2 (Rakoczy et al., 1993; Vagner et al., 1996) (Figure 4b,c) . Function of FGF2 might be redundant, and its absence might be compensated by another member of the FGF family.
Knockout mice for FGF3 (Mansour et al., 1993) , FGF5 (HeÂ bert et al., 1994), FGF6 (Fiore et al., 1997) or FGF7 (Guo et al., 1996) resulted only in mild phenotypes, whereas inactivation of other FGFs has more severe consequences (e.g. FGF4 or FGF10 (Feldman et al., 1995; Sekine et al., 1999) . The recent publication on double knockout FGF17/7 FGF27/7 mice seems to exclude that FGF1 can compensate for FGF2 de®ciency (Miller et al., 2000) .
Our work was focused on pigment cell tumors derived from the RPE, and the Tyrp1-Tag mouse model was very useful for this type of experiment. This was due to the reproducible phenotype, the low degree of variation and the possibility to obtain cell lines. However, the lack of eect in this model does not rule out that FGF2 might be required for certain speci®c types of tumors, as for example melanoma. FGF2 is a natural mitogen for melanocytes, and expression of FGF2 leads to decreased pigmentation and autonomous growth in melanocyte cell lines (Becker et al., 1989; Dotto et al., 1989) , and transforms melanocytes in human skin in combination with ultraviolet B (Berking et al., 2001) . Melanocytic lesions and melanomas in human do produce FGF2 (Reed et al., 1994; Scott et al., 1991) , and antisense oligonucleotides speci®cally directed against FGF2 eectively inhibit intratumoral angiogenesis and melanoma growth in nude mice (Wang and Becker, 1997) . This suggests that FGF2 could be implicated in melanocyte proliferation and melanoma formation. This hypothesis can be tested in future experiments using FGF2-de®cient mice and mouse models for melanoma (Beermann et al., 1999) .
Materials and methods
Inactivation of the mouse FGF2 gene
Genomic fragments of mouse FGF2 were isolated from a 129/Sv mouse genomic library (Stratagene) and subcloned into pBluescriptII (Stratagene). A 2.2 kb 5' homologous sequence (BglII-KpnI fragment) retaining part of exon 2, and a 4.5 kb 3' region derived from intron 2 (XbaI ± XhoI fragment) were cloned into vector pHM2 (Kaestner et al., 1994) . A MCl-tk cassette was added at the 5' end of the homology. Details of cloning are available on request. The vector was linearized at a unique XbaI site and electroporated into HM-1 embryonic stem cells (Magin et al., 1992) . Correctly targeted clones were expanded and injected into C57BL/6J blastocysts. High degree chimeras were obtained from two clones, which were bred to C57BL/6J mice. Germline transmission was obtained from three males and two females. Heterozygotes were further bred to C57BL/6J mice for at least six generations. Heterozygous and homozygous ospring were identi®ed by Southern blot analysis on DNA isolated from tail biopsies . Due to a restriction enzyme polymorphism the wild-type band is 6 kb in the strain C57BL/6J (not shown), and 7.5 kb in 129/Sv mice (Figure 1 ). Successive generations of mice were analysed by PCR using 3 primers (5'-tgatgaattcatgtgggggtgctttgatctc-3', 5'-gattgaattccaatgccagtaaatacctgc-3', 5'-gtgcatctgccagtttgagg), allowing to distinguish between the dierent genotypes (wildtype: 0.2 kb, FGF27/7: 0.5 kb).
Reverse transcription and PCR (RT ± PCR)
Total RNA was isolated from organs or cell cultures following standard procedures. RNA (2 mg) was transcribed into cDNA using oligo-dT and reverse transcriptase (Pharmacia), and PCR was performed using primers in exon 1 and exon 3 of mouse FGF2 (5'-agcggctctactgcaagaac-3' and 5'-tcgtttcagtgccacatacc-3'). Reaction was controlled using primers amplifying GAPDH (Hummler et al., 1996) .
Western blot
Con¯uent cells from six-well plates were extracted in 200 ml of extraction buer (20 mM Tris-HCl pH 7.5, 1% NP-40, 0.5% deoxycholate, 5 mM EDTA, 2 mM EGTA). Proteins were quanti®ed using the Biorad protein assay. For immunoblot analysis, 35 mg of proteins from RPE cells were resuspended in SDS loading buer, boiled at 958C for 5 min and run on SDS ± 15% PAGE. Proteins were electrophoretically transferred to nitrocellulose membranes in 20% methanol, 40 mM glycine, and 50 mM Tris base. After transfer, membranes were saturated with PBS containing 4% milk and 0.5% Tween 20 and probed overnight at 48C with anti-alpha-tubulin antibody or anti-FGF2 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted 1 : 500 in PBS/4% milk/0.5% Tween. Immunocomplexes were visualized by chemiluminescence using the ECL system (Amersham).
Tumor growth in Tyrp1-Tag transgenic mice Tyrp1-Tag transgenic mice were bred to FGF2+/-females to obtain Tyrp1-Tag FGF2+/7 ospring. These Tyrp1-Tag FGF2+/7 males were backcrossed to C57BL/6J for more than six generations. Tyrp1-Tag FGF27/7 mice were obtained by breeding these males to FGF2+/7 female littermates. For histological analysis, eyes were dissected, ®xed in 4% paraformaldehyde for 2 h and embedded in paran. 7 mm sections were stained with hematoxylin-eosin. For immunohistochemical detection of SV40 large T antigen slides were incubated with primary antibody KT3 (biotinylated anti-large T (MacArthur and Walter, 1984; Penna et al., 1998) , followed by secondary antibody (AF-conjugated streptavidin) and revealed using horseradish peroxidase kit (Roche). Blood vessels were revealed using rat monoclonal antibody to mouse CD31 (Pecam1, Caltag). Angiogenesis was quantitated by counting the number of vessels on two independent sections on an area corresponding to 8.59 mm 2 .
Isolation and intradermal injection of tumor cells RPE tumor cells were prepared from Tyrp1-Tag transgenic mice of FGF2+/+ or FGF27/7 genetic background . Eyes were dissected and single-cell suspension was obtained by mechanical sharing with tissue homogenizer. Cells were grown in DMEM+10% FCS. During the ®rst week, medium was changed every 2 days to remove dead cells and debris. Cells were kept in culture for at least 4 weeks and passaged more than 10 times, before freezing aliquots in liquid nitrogen. For injections, aliquots of cells were drawn, suspended in culture medium, and 2610 6 cells were injected subcutaneously in the back of anaesthetized mice. To obtain nude mice (Foxn1 nu homozygous) which were either wild-type, or heterozygous or homozygous mutant at the FGF2 gene locus, male mice heterozygous for the nude mutation, (Foxn1 nu , ISREC breeding colony) were crossed to FGF27/7 females, and Foxn1 nu /+FGF2+/7 ospring were interbred. In a ®rst experiment, RPE tumor cells of FGF27/7 genotype were injected into 10 mice of either Foxn1 nu /Foxn1 nu FGF2+/+ or FGF27/7 genetic background. Diameter and thickness of the tumor were measured once a week (FGF2+/+, 30 days n=10, 37 and 44 days n=9, 51 and 58 days n=8, FGF27/7, 30 days n=10, 37 days n=8, 44 days n=7, 51 days n=6, 58 days n=5). The relative high proportion of mice not surviving was obviously not caused by the tumors, but rather due to the requirement to quit the SPF (standardized pathogen-free) status for breeding purpose. Thus, for the second injection experiment, nude (Foxn1 nu /Foxn1 nu ) mice of the ISREC breeding colony were kept under SPF conditions and were injected with RPE tumor cells of FGF27/7 (n=5 mice) and FGF2+/+ genotype (n=4 mice). No dead mice were observed during this experiment and tumor growth was monitored weekly. Tumor growth rate was higher as in the ®rst experiment, which is most probably due to the dierent genetic background of the nude mouse strain.
